Lung Cancer
Volume 68, Issue 1 , Pages 10-15 , April 2010

Pain in patients with lung cancer: Pathophysiology and treatment

Received 28 July 2009 ,Revised 17 September 2009 ,Accepted 2 November 2009.

References 

  1. Schofield P, Ugalde A, Carey M, Mileshkin L, Duffy M, Ball D, et al. Lung cancer: challenges and solutions for supportive care intervention research. Pall Support Care. 2008;6:281–287
  2. Potter J, Higginson IJ. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology. Lung Cancer. 2004;43:247–257
  3. Barbera L, Paszat L, Qiu F. End-of-life care in lung cancer patients in Ontario: aggressiveness of care in the population and a description of hospital admissions. J Pain Symptom Manage. 2008;35:267–274
  4. Mercadante S, Armata M, Salvaggio L. Pain characteristics of advanced lung cancer patients referred to a palliative care service. Pain. 1994;59:141–145
  5. Wildgaard K, Ravn J, Kehlet H. Chronic post-thoractomy pain: a critical review of pathogenic mechanisms and strategies for prevention. Eur J Cardiol Thorac Surg. 2009;36:170–180
  6. Jaeckle KA. Neurological manifestations of neoplastic and radiation-induced plexopaties. Semin Neurol. 2004;24:385–393
  7. Portenoy RK, Miransky J, Thaler H, Hornung J, Bianchi C, Cibas-Kong I, et al. Pain in ambulatory patients with lung or colon cancer. Cancer. 1992;70:1616–1624
  8. Wilkie D, Hsiu-Ying H, Reilly N, Cain KA. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage. 2001;22:899–910
  9. Grond S, Zech D, Diefenbach C, Radbruch L, lehmann KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64:107–114
  10. Mercadante S. Malignant bone pain: physiopathology, assessment and treatment. Pain. 1997;69:1–18
  11. Mercadante S. Neoplasm-induced pain. In:  Gilman S editors. Neurobiology of disease. San Diego: Elsevier; 2007;p. 1007–1020
  12. Portenoy RK, Conn M. Cancer pain syndromes. In:  Bruera E,  Portenoy RK editor. Cancer pain, assessment and management. Cambridge University Press; 2003;p. 38–50
  13. Chi D, Behin A, Delattre JY. Neurologic complications of radiation therapy. In:  Schiff D,  Kesari S,  Wen PY editor. Current Clinical oncology: cancer neurology in clinical practice. Humana Press; 2008;p. 259–286
  14. Kori SH, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer: 100 cases. Neurology. 1981;31:45–50
  15. Balduyck B, Hendriks J, Lauwers P, Van Schil P. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients. Lung Cancer. 2007;56:423–431
  16. Balduyck B, Hendriks J, Lauwers P, Van Schil P. Quality of life after lung cancer surgery: a prospective pilot study comparing bronchial sleeve lobectomy with pneumonectomy. J Thorac Oncol. 2008;3:604–608
  17. Balduyck B, Hendriks J, Lauwers P, Van Schil P. Quality of life evolution after lung cancer surgery in septuagenarians: a prospective study. Eur J Cardiol Thorac Surg. 2009;35:1070–1075
  18. Hanks GW Expert Working Group of the Research Network of the EAPC. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587–593
  19. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. JAMA. 1995;274:1870–1873
  20. Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Ficorella C, et al. Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage. 2006;31:242–247
  21. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence, and characteristics. Pain. 1990;41:273–281
  22. Cherny NJ, Chang V, Frager G, Ingham JM, Tiseo PJ, Popp B, et al. Opioid pharmacotherapy in the management of cancer pain. Cancer. 1995;76:1288–1293
  23. Mercadante S. Cancer pain. In:  Schiff D,  Kesari S,  Wen PY editor. Cancer neurology in clinical practice. Humana Press; 2008;p. 113–128
  24. Clemens KE, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage. 2007;33(April (4)):473–481
  25. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain. 2009;13:331–338
  26. Mercadante S Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer. 2002;94:832–839
  27. Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev. 2006;32:304–315
  28. Bolan E, Tallarida R, Pasternak G. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther. 2002;303:557–562
  29. Mercadante S, Villari P, Ferrera P, Casuccio A. Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer. 2004;12:762–766
  30. Portenoy RK, Rowe G. Adjuvant analgesic drugs. In:  Bruera E,  Portenoy RK editor. Cancer pain, assessment and management. Cambridge University Press; 2003;p. 188–198
  31. Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori. 2002;88:239–242
  32. Caraceni A, Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M, et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol. 2004;22:2909–2917
  33. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain. 1999;79:1–13
  34. Mercadante S, Intravaia G, Villari P, Ferrera P, Riina S, David F, et al. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain. 2007;23:793–798
  35. Tasker RR. Neurosurgical and neuroaugmentative intervention. In:  Patt RB editors. Cancer pain. Philadelphia: JB Lippincott Co.; 1993;p. 471–500

PII: S0169-5002(09)00581-9

doi: 10.1016/j.lungcan.2009.11.004

Lung Cancer
Volume 68, Issue 1 , Pages 10-15 , April 2010

Article Tools